LIFE SCIENCES AND PHARMACEUTICAL INDUSTRIAL AUTOMATION AND CONTROL SYSTEMS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)
The global life sciences and pharmaceutical industrial automation and control systems market size is expected to stand at USD 26,328.2 Mn in 2026 and is projected to reach USD 55,546.7 Mn by 2033, expanding at a compound annual growth rate (CAGR) of 11.3% from 2026 to 2033. The global life sciences and pharmaceutical industrial automation and control systems market is undergoing significant transformation as pharmaceutical, biotechnology, medical device and laboratory facilities increasingly adopt automated technologies across manufacturing, processing, packaging, quality assurance and material handling operations Solutions such as programmable logic controllers, distributed control systems, supervisory control and data acquisition, manufacturing execution systems, robotics, industrial sensors and human machine interfaces are being deployed to enhance process accuracy, operational consistency and production visibility Increasing manufacturing of biologics, vaccines, cell and gene therapies and other complex pharmaceutical products is further strengthening the need for precise and reliable automation and process control capabilities.
Market Dynamics
The market is being influenced strongly by the shift toward automated and continuous pharmaceutical manufacturing, particularly across biologics and other technically complex production processes Pharmaceutical companies are implementing automated process control, real time monitoring, robotic handling and process analytical technologies to minimize production variability and maintain consistent quality standards Increasing emphasis on electronic documentation, product traceability, data integrity and validated manufacturing processes is also encouraging companies to replace outdated control systems and establish stronger connections between automation platforms and quality management infrastructure Furthermore, the growing adoption of personalized medicines and smaller production batches is increasing demand for flexible automation systems capable of supporting variable production requirements
Technological advancement is simultaneously reshaping the market through the integration of artificial intelligence, machine learning, edge computing, digital twins and industrial cybersecurity into automation architectures Predictive analytics is increasingly being used to identify potential equipment failures and process deviations, while digital twin technologies enable manufacturers to simulate production processes and optimize system configurations before implementing physical modifications Nevertheless, substantial investment requirements, stringent validation procedures, cybersecurity vulnerabilities and integration difficulties involving legacy systems remain important barriers to wider deployment These factors are increasing demand for modular, interoperable, scalable and cybersecurity focused automation solutions capable of supporting both established pharmaceutical facilities and newly developed smart manufacturing environments.
Key features of the study
Market Segmentation
Market Segmentation
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
